Endoxifen for breast cancer: Multiple-dose, dose-escalation study characterizing pharmacokinetics and safety in metastatic breast cancer patients.

被引：0
|
作者：
Ahmad, Ateeq
Sheikh, S.
Nagarkar, R.
Singh, J. K.
Krishnan, S.
Shrivastav, S.
Shetty, P.
Kale, P.
Rane, R. C.
Ahmad, I.
机构：
[1] Jina Pharmaceut Inc, Libertyville, IL USA
[2] Curie Manavata Canc Ctr, Nasik, India
[3] Mahavir Canc Sansthan, Patna, Bihar, India
[4] Dr Rai Mem Med Ctr, Madras, Tamil Nadu, India
[5] Lions Canc Detect & Treatment Ctr, Surat, India
[6] Lambda Therapeut Res Ltd, Ahmadabad, Gujarat, India
[7] Intas Pharmaceut Ltd, Ahmadabad, Gujarat, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3089
引用
收藏
页数：1
相关论文
共 50 条
  • [31] First-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy
    Avisar, Noa
    Adar, Liat
    Bock, Jason
    Mueller, Udo
    Shen, David
    Barash, Steve
    Pukac, Laurie
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (05) : 929 - 939
  • [32] Toxicity Evaluation of Dose-Escalation in Hypofractionated Regional Nodal Irradiation for Breast Cancer: A Retrospective Study
    Kim, Euidam
    Yoo, Ji Sung
    Kim, Yeon-Joo
    Joo, Jungnam
    Oh, Eun Sang
    Chung, Yoonsun
    Chung, Seung Hyun
    Kim, Tae Hyun
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (03): : 823 - 834
  • [33] Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2-positive breast cancer: An open-label, dose-escalation, phase I study
    Hong, Ruoxi
    Xia, Wen
    Wang, Liye
    Lee, Kaping
    Lu, Qianyi
    Jiang, Kuikui
    Li, Shengfeng
    Yu, Jinquan
    Wei, Jin
    Tang, Weijia
    Zhou, Danyang
    An, Xin
    Huang, Jiajia
    Xue, Cong
    Bi, Xiwen
    Shi, Yanxia
    Yuan, Zhongyu
    Xu, Fei
    Wang, Shusen
    CANCER COMMUNICATIONS, 2021, 41 (02) : 171 - 182
  • [34] Phase Ib dose-escalation study of eribulin in combination with capecitabine in patients with advanced/metastatic cancer
    Savulsky, C.
    Nasim, M.
    Plummer, R.
    Evans, J.
    Morrison, R.
    Anthoney, A.
    Haney, S.
    Madi, A.
    Johnston, C.
    Carter, D.
    Reydermann, L.
    Gopalakrishna, P.
    Wanders, J.
    Twelves, C.
    ONKOLOGIE, 2012, 35 : 153 - 154
  • [35] Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
    John Sarantopoulos
    Alain C. Mita
    Aiwu He
    James L. Wade
    Chung-Tsen Hsueh
    John C. Morris
    A. Craig Lockhart
    David I. Quinn
    Jimmy Hwang
    James Mier
    Wenping Zhang
    Claudine Wack
    Jian Yin
    Pierre-François Clot
    Olivier Rixe
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 339 - 351
  • [36] DOSE-ESCALATION OF MITOXANTRONE GIVEN WITH THIOTEPA AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR METASTATIC BREAST-CANCER
    BOWERS, C
    ADKINS, D
    DUNPHY, F
    HARRISON, B
    LEMAISTRE, CF
    SPITZER, G
    BONE MARROW TRANSPLANTATION, 1993, 12 (05) : 525 - 530
  • [37] Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
    Sarantopoulos, John
    Mita, Alain C.
    He, Aiwu
    Wade, James L.
    Hsueh, Chung-Tsen
    Morris, John C.
    Lockhart, A. Craig
    Quinn, David I.
    Hwang, Jimmy
    Mier, James
    Zhang, Wenping
    Wack, Claudine
    Yin, Jian
    Clot, Pierre-Francois
    Rixe, Olivier
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (02) : 339 - 351
  • [38] PHARMACOKINETICS OF ERIBULIN MESILATE IN COMBINATION WITH CAPECITABINE IN PATIENTS WITH ADVANCED/METASTATIC CANCER: RESULTS FROM A PHASE IB DOSE-ESCALATION STUDY
    Twelves, C. J.
    Nasim, M.
    Anthoney, A.
    Cresti, N.
    Savulsky, C.
    Johnston, C.
    Reyderman, L.
    Wanders, J.
    Plummer, R.
    Evans, T. R. J.
    ANNALS OF ONCOLOGY, 2012, 23 : 129 - 129
  • [39] A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients
    Van Cutsem, E.
    Verslype, C.
    Beale, P.
    Clarke, S.
    Bugat, R.
    Rakhit, A.
    Fettner, S. H.
    Brennscheidt, U.
    Feyereislova, A.
    Feyereislova, A.
    Delord, J. -P.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 332 - 339
  • [40] Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study
    Awada, A.
    Albanell, J.
    Canney, P. A.
    Dirix, L. Y.
    Gil, T.
    Cardoso, F.
    Gascon, P.
    Piccart, M. J.
    Baselga, J.
    BRITISH JOURNAL OF CANCER, 2008, 98 (09) : 1500 - 1507
12345